Cited by 36Advanced Drug Delivery SystemsOcular Infections and TreatmentsNanoparticle-Based Drug Delivery

Reduced administration frequency for the treatment of fungal keratitis: a sustained natamycin release from a micellar solution

Guo, Yiyuan, Karimi, Fatemeh, Fu, Qiang, G. Qiao, Greg., Zhang, Hong·2020·Expert Opinion on Drug Delivery

Abstract

Background Natamycin is the only topical ophthalmic antifungal drug approved by the Food and Drug Administration (FDA) of the United States, but has unsatisfactory factors such as high dosing frequency.Methods We report the synthesis and preparation of self-assembled poly(ethylene glycol)-block-poly(glycidyl methacrylate) (PEG-b-PGMA) micelles. These nanoparticles exhibit sustained delivery of a hydrophobic natamycin by topical administration on eye due to the hydrolysable properties of PGMA segments of micelle. Hydrolysis of glycidyl groups within a physiologically relevant environment provides an additional driving force for drug release by generation of hydrophilic hydroxyl groups to ‘push’ the encapsulated hydrophobic drug away from the resultant hydrophilic domains and into surrounding environment.Results In vitro and in vivo results revealed that the self-assembled micelles and the encapsulated natamycin were not cytotoxic and the released drug have strong antifungal ability to Candida albicans. Importantly, sustained natamycin release from micelles leads to the reduced administration frequency of natamycin from 8 times per day to 3 times per day in rabbits suffering from fungal keratitis (FK).Conclusion This study demonstrates a facile method that can greatly reduce dosing frequency of natamycin administration and thus improve long-term patient compliance.

Integrity signals

Registry

Crossref · 10.1080/17425247.2020.1719995

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The incorporation of PGMA into PEG-PGMA micelles endows them with controlled release since PGMA can be hydrolyzed to yield hydrophilic hydroxyl groups at neutral pH.

    “The incorporation of PGMA into PEG–PGMA micelles endows them with the characteristics of controlled release since PGMA can be hydrolyzed to yield hydrophilic hydroxyl groups at neutral pH [209].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Guo, Y., Karimi, F., Fu, Q., G. Qiao, G., & Zhang, H.
Affiliations
  • Harbin Medical University (CN)
  • The University of Melbourne (AU)
  • University of Technology Sydney (AU)
  • Department of Chemical Engineering, The University of Melbourne, Melbourne, Australia
Corresponding author
Zhang, Hong
Venue
Expert Opinion on Drug Delivery
Published
2020-02-03
Volume
17
Issue
3
Pages
407-421
ISSN
  • 1742-5247 (ISSN-L)
  • 1744-7593
OpenAlex
W3004564308
Cited by
36
References
44
Citations by year
2026: 3 · 2025: 6 · 2024: 6 · 2023: 6 · 2022: 4 · 2021: 8 · 2020: 3
FWCI
2.05
Type
journal article
Language
en
Open access
closed
Locations
  • Expert Opinion on Drug Delivery (publishedVersion)
  • PubMed (publishedVersion)
  • Minerva Access (University of Melbourne) (submittedVersion)
  • OPUS - Open Publications of UTS Scholars (University of Technology Sydney) (submittedVersion)
Funders
  • National Natural Science Foundation of China (81970776; 81671844)
  • Australian Research Council under the ARC Linkage (LP150100315)
  • The Scientific Research Transformation of Foundation of Heilongjiang Academy of Medical Sciences (CR201809)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
Keywords
natamycin, fungal keratitis, sustained drug release, micelles, nanoparticle self-assembly, Candida albicans, reduced dosing frequency, medication adherence
MeSH terms
Administration, Topical, Animals, Antifungal Agents, Humans, Keratitis, Micelles, Natamycin, Rabbits, Eye Infections, Fungal, Nanoparticles, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review